DSDaniel Scurtu

Daniel Scurtu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel Scurtu has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk factors for surgical site infections after spinal surgery: a systematic review and meta-analysis

    by Sophie-Liliane Rosenke, Myles Kisekka, Hiend Darweesh, Brawin Kajenthra, Jake Hewitt, Daniele Ramsay, Hariharan Subbiah Ponniah, Dragan Jankovic, Daniel Scurtu, Darius Kalasauskas, et al.

    Purpose: Surgical site infections (SSIs) are a serious complication of spinal surgery, leading to prolonged hospital stays, increased healthcare costs, and worse patient outcomes. This review aimed to synthesise current evidence on modifiable risk factors for SSIs in spinal surgery to identify targets for intervention, perioperative optimisation, and improve patient care. Methodology: A systematic search of MEDLINE, Embase, Scopus, Academic Search Ultimate, and CINAHL was conducted on 10 March 2024. Risk of bias was assessed using the Newcastle-Ottawa Scale, ROBINS-E, and the Oxford Centre for Evidence-Based Medicine: Levels of Evidence. A random-effects meta-analysis generated pooled odds ratios (ORs) with 95% confidence intervals (CI). Heterogeneity was assessed using I², Cochran’s Q, and associated p-values. Sensitivity and influence analyses evaluated the robustness. Results: Forty-four studies were included, comprising 637,032 patients and 9,745 SSIs. Modifiable risk factors associated with increased SSI risk included body mass index, diabetes mellitus (including insulin-dependent), smoking, low preoperative haematocrit (< 33–39%), and chronic steroid use. Subcutaneous fat thickness > 30 mm and operative time > 2 h were also considered partially modifiable. Intraoperative vancomycin powder significantly reduced SSI risk. Non-modifiable risk factors included (American Society of Anaesthesiologists) ASA ≥ 3, female sex, coronary artery disease, revision surgery and procedures involving ≥ 3 vertebral levels. Age, alcohol use, albumin levels, instrumentation and blood transfusion were not significantly associated. High heterogeneity was noted for several variables, particularly BMI and diabetes. Conclusion: Several modifiable risk factors for SSIs were identified. Intraoperative vancomycin powder showed a protective effect. These findings offer perioperative strategies including glycaemic control, smoking cessation, anaemia management, and steroid dose adjustments to reduce SSI incidence and improve outcomes.


  • Open Access

    Pediatric Intracranial Infections Requiring Neurosurgery: A German Multicenter Analysis of 10-Year Trends Pre–COVID-19 and Post–COVID-19

    by Daniel Dubinski, Sae-Yeon Won, Artem Rafaelian, Ulrich Sure, Phillipp Dammann, Laurèl Rauschenbach, Christian Senft, Nazife Dinc, Nazeer Aboud, Florian Ringel, et al.

    BACKGROUND AND OBJECTIVES: Intracranial infection in children is a rare but life-threatening condition that requires immediate neurosurgical care. The impact of the COVID-19 pandemic on incidence and outcome is unclear. METHODS: This study is a multicenter retrospective analysis of children who underwent neurosurgical treatment of intracranial infections (epidural abscess, subdural empyema, cerebral abscess, ventriculitis, and meningitis) between January 2014 and October 2024. Comparison of children with intracranial infections and neurosurgical intervention stratified by pre and postpandemic. RESULTS: The annual incidence of pediatric intracranial infections requiring neurosurgery increased significantly from 5.6 cases (95% CI: 4.0-7.5) prepandemic to 14.4 cases (95% CI: 11.2-18.0) postpandemic, with an incidence risk ratio (IRR) of 2.6 (95% CI: 1.8-3.8; P < .0001). Causative were the observed sinusitis-associated cases, with absolute numbers rising from 13 prepandemic to 31 postpandemic. The annual incidence increased from 1.81 cases (95% CI: 0.99-2.97) to 6.45 cases (95% CI: 4.44-9.00), yielding an IRR of 3.6 (95% CI: 1.9-7.1; P = .0001). For otitis-related cases, absolute counts surged from 6 to 19, accompanied by an incidence increase from 0.83 (95% CI: 0.33-1.69) to 3.95 (95% CI: 2.43-6.01), with an IRR of 4.7 (95% CI: 2.0-13.0; P = .0009). However, functional outcomes assessed by the pediatric modified Rankin Scale showed no statistically significant differences between pre- and postpandemic cohorts in the Wilcoxon-Mann-Whitney test, both at discharge ( P = .388) and at 3-month follow-up ( P = .927). CONCLUSION: Our study demonstrates a significant increase in the incidence of intracranial infections requiring neurosurgical treatment in children after the pandemic, with a 2.4-fold higher IRR compared with the prepandemic period. The postpandemic group had a significantly higher incidence of underlying complicated otitis and sinusitis.